Literature DB >> 3922455

Elevated adenosine deaminase and purine nucleoside phosphorylase activity in peripheral blood null lymphocytes from patients with acquired immune deficiency syndrome.

J L Murray, K C Loftin, C G Munn, J M Reuben, P W Mansell, E M Hersh.   

Abstract

The purine metabolic enzymes adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) are important in lymphocyte differentiation, and genetic deficiencies of either enzyme have been associated with hereditary immunodeficiency states. Both ADA and PNP activity were measured in null cell-enriched and T cell-enriched peripheral blood lymphocytes from 16 patients with the acquired immune deficiency syndrome (AIDS), seven patients with the AIDS-related symptom complex (ARC), and seven asymptomatic homosexuals. ADA activity in nmol/10(6) lymphocytes/h was significantly elevated in null lymphocytes from AIDS (161 +/- 12) as compared with 23 healthy heterosexual controls (127 +/- 8;P less than .025). PNP activity was also significantly increased in null lymphocytes from AIDS patients (96 +/- 10;P less than .005) as well as those from ARC patients (84 +/- 11:P less than .025) relative to controls (61 +/- 5). No significant differences in enzyme activity were noted in T cell-enriched cells in any group. Along with elevated enzyme activity, AIDS patients had small yet significant increases in the percentages of HLA-DR (P less than .025), terminal deoxynucleotidyl transferase (TdT) (P less than .0001), and peanut agglutinin receptor (P less than .0001) positive lymphocytes in the null fraction compared with controls. TdT-positive cells appeared morphologically as large lymphoblasts with irregular nuclei. The data imply that the cellular immune deficiency in AIDS is not a result of deficiencies in lymphocyte ADA or PNP activity, but is more likely associated with an increase in an immature and/or activated lymphocyte subset.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3922455

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

Review 1.  Adenosine signaling and adenosine deaminase regulation of immune responses: impact on the immunopathogenesis of HIV infection.

Authors:  Daniela F Passos; Viviane M Bernardes; Jean L G da Silva; Maria R C Schetinger; Daniela Bitencourt Rosa Leal
Journal:  Purinergic Signal       Date:  2018-08-10       Impact factor: 3.765

2.  Surface expression of adenosine deaminase in mitogen-stimulated lymphocytes.

Authors:  M Martin; J J Centelles; J Huguet; F Echevarne; D Colomer; J L Vives-Corrons; R Franco
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

3.  Elevated erythrocyte adenosine deaminase activity in patients with acquired immunodeficiency syndrome.

Authors:  M J Cowan; R O Brady; K J Widder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

4.  Immunological dysfunction in HIV-1-infected individuals caused by impairment of adenosine deaminase-induced costimulation of T-cell activation.

Authors:  José M Martinez-Navio; Núria Climent; Rodrigo Pacheco; Felipe Garcia; Montserrat Plana; Meritxell Nomdedeu; Harold Oliva; Cristina Rovira; Laia Miralles; José M Gatell; Teresa Gallart; Josefa Mallol; Carme Lluis; Rafael Franco
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

5.  Artificial Neural Network-Based Study Predicts GS-441524 as a Potential Inhibitor of SARS-CoV-2 Activator Protein Furin: a Polypharmacology Approach.

Authors:  M Dhanalakshmi; Kajari Das; Medha Pandya; Sejal Shah; Ayushman Gadnayak; Sushma Dave; Jayashankar Das
Journal:  Appl Biochem Biotechnol       Date:  2022-10       Impact factor: 3.094

6.  A new strategy based on pharmacophore-based virtual screening in adenosine deaminase inhibitors detection and in-vitro study.

Authors:  Roya Bazl; Mohammad Reza Ganjali; Ali-Akbar Saboury; Alireza Foroumadi; Parviz Nourozi; Massoud Amanlou
Journal:  Daru       Date:  2012-10-22       Impact factor: 3.117

7.  Serum adenosine deaminase activity and coronary artery disease: a retrospective case-control study based on 9929 participants.

Authors:  Chao Xuan; Qing-Wu Tian; Shao-Yan Zhang; Hui Li; Ting-Ting Tian; Peng Zhao; Kang Yue; Yan-Yan Ling; Guo-Wei He; Li-Min Lun
Journal:  Ther Adv Chronic Dis       Date:  2019-12-06       Impact factor: 5.091

8.  The relationship between adenosine deaminase and heart rate-corrected QT interval in type 2 diabetic patients.

Authors:  Chun-Feng Lu; Xiao-Qin Ge; Yan Wang; Jian-Bin Su; Xue-Qin Wang; Dong-Mei Zhang; Feng Xu; Wang-Shu Liu; Min Su
Journal:  Endocr Connect       Date:  2021-08-03       Impact factor: 3.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.